Prosthetic heart valves

Patent metadata

Field	Value
Publication number	US-12150853-B2
Application number	US-202318349278-A
Country	US
Kind code	B2
Filing date	Jul 10, 2023
Priority date	Jun 4, 2007
Publication date	Nov 26, 2024
Grant date	Nov 26, 2024

Abstract

A prosthetic heart valve (e.g., a prosthetic aortic valve) is designed to be somewhat circumferentially collapsible and then re-expandable. The collapsed condition may be used for less invasive delivery of the valve into a patient. When the valve reaches the implant site in the patient, it re-expands to normal operating size, and also to engage surrounding tissue of the patient. The valve includes a stent portion and a ring portion that is substantially concentric with the stent portion but downstream from the stent portion in the direction of blood flow through the implanted valve. When the valve is implanted, the stent portion engages the patient's tissue at or near the native valve annulus, while the ring portion engages tissue downstream from the native valve site (e.g., the aorta).

First claim

The invention claimed is:

1. A prosthetic heart valve, comprising:
a collapsible and expandable stent assembly having first stent portion and a second stent portion, the first stent portion is coupled to the second stent portion to form an independent stent-in-stent design, the first stent portion and the second stent portion each being formed of nitinol so that each of the first stent portion and the second stent portion is self-expandable;
a plurality of valve leaflets coupled directly to the second stent portion but not directly to the first stent portion, the plurality of valve leaflets configured to allow blood to flow in a downstream direction, but to restrict blood from flowing in an upstream direction;
a first fabric at least partially covering an exterior surface of the first stent portion; and
a plurality of projections formed on the first stent portion and extending in the upstream direction, the plurality of projections remaining uncovered by the first fabric so that the projections are configured to engage tissue to prevent migration of the prosthetic heart valve in the upstream direction when the stent assembly is in an expanded condition,
wherein in the expanded condition of the stent assembly, the first stent portion has an expanded diameter that is greater than an expanded diameter of the second stent portion,
wherein the first stent portion is coupled to the second stent portion via a plurality of individual attachment links that are positioned at spaced locations around a circumference of the stent component,
wherein the first stent portion includes at least one circumferential row of closed-perimeter cells,
wherein the closed-perimeter cells are diamond-shaped,
wherein in the expanded condition of the stent assembly, an inflow end of stent assembly flares radially outwardly from a remainder of the stent assembly, the flare configured to help secure the stent assembly in place,
wherein a second fabric is coupled to the second stent portion,
wherein, in the expanded condition of the stent assembly, the first stent portion is spaced from the second stent portion so that the plurality of valve leaflets cannot contact the first stent portion during operation of the prosthetic heart valve,
wherein, in the expanded condition of the stent assembly, the first stent portion is substantially concentric with the second stent portion,
wherein the second stent portion includes three commissure regions, the plurality of valve leaflets being coupled to the three commissure regions,
wherein, during operation of the prosthetic heart valve, the three commissure regions are spaced radially inwardly from the first stent portion so that a gap exists between an outer surface of the three commissure regions and an inner surface of the first stent portion,
wherein the independent stent-in-stent design is configured to allow the three commissure regions to flex independently of the first stent portion.

2. The prosthetic heart valve of claim 1 , wherein the projections are barbs.

3. The prosthetic heart valve of claim 1 , wherein the first stent portion is configured to anchor the prosthetic heart valve within a heart so that the plurality of valve leaflets are positioned within a native valve annulus of the heart.

4. The prosthetic heart valve of claim 3 , wherein, in the expanded condition of the stent assembly, the first stent portion is generally tubular or cylindrical.

5. The prosthetic heart valve of claim 3 , wherein the plurality of individual attachment links are positioned a spaced distance below the three commissure regions.

Assignees

• St Jude Medical Llc

Inventors

• Braido Peter N
• Alkhatib Yousef F

Classifications

• A61L27/54

  Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

• A61L27/3604

  characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title

• A61F2210/0076

  multilayered, e.g. laminated structures · CPC title

• A61F2230/008

  paraboloidal · CPC title

• A61F2230/0054

  V-shaped · CPC title